Prolonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitis. [electronic resource]
Producer: 20120913Description: 3280-6 p. digitalISSN:- 1460-2385
- Adult
- Aged
- Aged, 80 and over
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis -- drug therapy
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cyclophosphamide -- administration & dosage
- Female
- Follow-Up Studies
- Humans
- Kidney Diseases -- drug therapy
- Male
- Middle Aged
- Prospective Studies
- Remission Induction
- Rituximab
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.